Dido Lenze

Dido Lenze is currently a Diagnostic Manager for New Biomarkers and Innovation at AstraZeneca, where they have held several key roles since 2018, including Diagnostic Liaison Manager and Diagnostic Manager HER2. Prior to their time at AstraZeneca, Dido worked at Charité from 2010 to 2018 as a Deputy Head of Molecular Diagnostics and a Scientific Collaborator. Dido earned a doctoral degree (Dr. rer. nat.) from Charité-Universitätsmedizin Berlin and holds a Diplom in Biology from Freie Universität Berlin, complemented by earlier studies at Universität des Saarlandes and Freie Universität.